Simotinib
CAS No. 944258-89-3
Simotinib ( SIM6802;SIM-6802 )
Catalog No. M16764 CAS No. 944258-89-3
Simotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 258 | Get Quote |
|
50MG | 1269 | Get Quote |
|
100MG | 1791 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSimotinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionSimotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.
-
DescriptionSimotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.Lung Cancer Phase 1 Clinical
-
SynonymsSIM6802;SIM-6802
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research AreaCancer
-
IndicationLung Cancer
Chemical Information
-
CAS Number944258-89-3
-
Formula Weight500.95
-
Molecular FormulaC25H26ClFN4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=C(OCCN2CC3(C4(OCCO4)C2)CC3)C=C(C(NC5=CC=C(F)C(Cl)=C5)=NC=N6)C6=C1
-
Chemical NameN-(3-chloro-4-fluorophenyl)-6-(2-(5,8-dioxa-11-azadispiro(2.0.4.3)undec-11-yl)ethoxy)-7-methoxy-4-quinazolinamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang L, et al. Anticancer Drugs. 2016 Apr;27(4):300-11.
molnova catalog
related products
-
Anlotinib
Anlotinib (AL-3818) is a novel multi-target tyrosine kinase that primarily inhibit VEGFR2/3, FGFR1-4, PDGFR α/β, c-Kit, and Ret.
-
Dihydroberberine
Dihydroberberine has anti-atherosclerotic anti-inflammatory hypolipidemic and antitumor activities. It inhibits human ether-a-go-go-related gene (hERG) channels and remarkably reduces Hsp90 expression and its interaction with hERG.
-
Benidipine hydrochlo...
Benidipine HCl is a hydrochloride salt form of benidipine which is a dihydropyridine calcium channel blocker.